These results suggested that MTCH1-deficiency reduced mitochondrial NAD+ levels and inhibited FoxO1 activation, which subsequently downregulated GPX4 transcription and accumulated ROS, ultimately triggering ferroptosis in cervical cancer cells. Here, FOXO1 is linked to cervical carcinoma.